Companion Animal Healthcare Market Size - By Product (Pharmaceuticals {Drugs Vaccines, Medicated Feed Additives}, Medical Devices, Veterinary Services), By Animal Type, By Distribution Channel, Global Forecast, 2023

Description

List of Tables

Companion Animal Healthcare Market size is projected to expand at 7.9% CAGR from 2023 to 2032 driven by changing consumer preferences along with the evolving trend toward premium pet care and personalized veterinary services.

The surging demand for advanced veterinary treatments, premium pet food, and innovative healthcare products and services is expected to provide lucrative growth opportunities to the industry participants. With the rising technology advances, businesses are focusing on improving tech-led interventions to enhance the user experience and deliver excellent doorstep pet care services, further favoring the industry expansion. For instance, in June 2023, Cargill entered the pet care business with Zoonivet, a pet-care app, to streamline pet healthcare by offering simple and convenient veterinary services to pets via e-consultation accessible to pet owners across India.

The companion animal healthcare industry is categorized based on product, animal type, distribution channel, and region.

The market share from the pharmaceuticals product segment is projected to gain significant traction from 2023-2032 driven by the rising demand for effective treatments and medications for pets. Numerous pharmaceutical companies, lately, are focusing on developing innovative and specialized healthcare products tailored to the unique needs of companion animals. Additionally, the growing emphasis on pet wellness and preventive care will accelerate the segment growth.

Based on the distribution channel, the companion animal healthcare industry from the E-commerce segment is estimated to record notable expansion by 2032 driven by the rising trend of online pet product purchases. The convenience of online shopping and the availability of wider product range at competitive prices is surging the preference for online platforms. Additionally, the easy access to variety of pet medications, supplements, and grooming products for catering to the growing demand for convenient and hassle-free shopping experiences will propel the segment growth.

Europe companion animal healthcare industry is estimated to expand at notable CAGR from 2023-2032 propelled by the increasing rate of pet adoption and the growing focus on pet health and wellness. Furthermore, the presence of favorable regulatory environment and stringent quality standards will drive the development of innovative and specialized healthcare solutions for pets, further augmenting the industry outlook. For instance, in October 2023, Accord Healthcare, a prominent pharmaceutical firm in Europe, developed an Animal Health division to help veterinarians and veterinarian practices with streamlined formulations, administration, and supplies.

Product Code: 6618

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Companion Animal Healthcare industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Animal type trends
- 2.1.5 Distribution channel trends

Chapter 3 Companion Animal Healthcare Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing population of pet animals
  - 3.2.1.2 Increasing support offered by government and public organizations for animal care
  - 3.2.1.3 Growing demand for online veterinary pharmacies
  - 3.2.1.4 Increase in animal healthcare expenditure
  - 3.2.1.5 Increasing adoption of pet insurance
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with animal health drugs
  - 3.2.2.2 Limited access in rural areas
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By animal type
- 3.3.3 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Companion Animal Healthcare Market Size and Forecast, By Product, 2018 - 2032 (USD Million)

5.1 Key trends, by product
5.2 Pharmaceuticals
- 5.2.1 Drugs
  - 5.2.1.1 Anti-parasitic
  - 5.2.1.2 Anti-infectives
  - 5.2.1.3 Anti-inflammatory
  - 5.2.1.4 Other drugs
- 5.2.2 Vaccines
  - 5.2.2.1 Modified live vaccines
  - 5.2.2.2 Killed inactivated vaccines
  - 5.2.2.3 Other vaccines
- 5.2.3 Medicated feed additives
  - 5.2.3.1 Antibiotics
  - 5.2.3.2 Vitamins
  - 5.2.3.3 Enzymes
  - 5.2.3.4 Amino acids
  - 5.2.3.5 Antioxidants
  - 5.2.3.6 Prebiotics and probiotics
  - 5.2.3.7 Minerals
  - 5.2.3.8 Other medicated feed additives
5.3 Medical devices
- 5.3.1 Veterinary diagnostic equipment
- 5.3.2 Veterinary anesthesia equipment
- 5.3.3 Veterinary patient monitoring equipment
- 5.3.4 Veterinary surgical equipment
- 5.3.5 Veterinary consumables
- 5.3.6 Other medical devices
5.4 Veterinary services

Chapter 6 Companion Animal Healthcare Market Size and Forecast, By Animal type, 2018 - 2032 (USD Million)

6.1 Key trends, by animal type
6.2 Dogs
6.3 Cats
6.4 Horses
6.5 Other companion animals

Chapter 7 Companion Animal Healthcare Market Size and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

7.1 Key trends, by distribution channel
7.2 Pharmacies
7.3 Distributors
7.4 E-commerce

Chapter 8 Companion Animal Healthcare Market Size and Forecast, By Region, 2018 - 2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East & Africa

Chapter 9 Company Profiles

9.1 Boehringer Ingelheim International GmbH
9.2 Elanco Animal Health
9.3 Merck & Co. Inc.
9.4 Vetoquinol SA
9.5 Zoetis, Inc.
9.6 Medtronic plc
9.7 IDEXX Laboratories
9.8 Neogen Corporation
9.9 Virbac SA
9.10 B Braun Melsungen AG